GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Guangxi LiuYao Group Co 603368.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

16.78

-1.93%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥20.93bn

FY2016FY2025

Net income

CN¥709.5m

FY2016FY2025

Free cash flow

CN¥893.2m

FY2016FY2025

Shareholders' equity

CN¥7.83bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥20.93bnCN¥21.18bnCN¥20.81bnCN¥19.05bnCN¥17.13bnCN¥15.67bnCN¥14.86bnCN¥11.71bnCN¥9.45bnCN¥7.56bn
Gross profitCN¥2.31bnCN¥2.38bnCN¥2.44bnCN¥2.15bnCN¥1.92bnCN¥1.91bnCN¥1.77bnCN¥1.24bnCN¥893.7mCN¥702.0m
Research and developmentCN¥38.5mCN¥42.7mCN¥36.6mCN¥25.8mCN¥18.6mCN¥8.7mCN¥2.8m———
Operating incomeCN¥1.09bnCN¥1.00bnCN¥1.04bnCN¥1.11bnCN¥957.2mCN¥1.09bnCN¥1.04bnCN¥666.3mCN¥506.7mCN¥402.4m
Net incomeCN¥709.5mCN¥854.9mCN¥849.6mCN¥701.5mCN¥563.8mCN¥711.7mCN¥685.4mCN¥528.2mCN¥401.4mCN¥321.0m
Diluted earnings per share1.792.142.371.941.561.971.891.451.110.89

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥21.34bnCN¥21.27bnCN¥20.16bnCN¥18.61bnCN¥15.87bnCN¥14.81bnCN¥11.96bnCN¥9.77bnCN¥7.55bnCN¥6.28bn
Cash and short-term investments—CN¥3.68bnCN¥3.47bnCN¥3.85bnCN¥3.42bnCN¥3.50bnCN¥1.92bnCN¥1.24bnCN¥1.07bnCN¥1.72bn
Total liabilitiesCN¥13.20bnCN¥13.33bnCN¥13.10bnCN¥12.24bnCN¥10.07bnCN¥9.36bnCN¥7.30bnCN¥5.73bnCN¥3.99bnCN¥3.04bn
DebtCN¥540.3mCN¥4.08bnCN¥4.42bnCN¥4.34bnCN¥3.92bnCN¥3.63bnCN¥2.25bnCN¥1.75bnCN¥623.7mCN¥263.0m
Shareholders' equityCN¥7.83bnCN¥7.62bnCN¥6.62bnCN¥5.97bnCN¥5.46bnCN¥5.10bnCN¥4.37bnCN¥3.85bnCN¥3.49bnCN¥3.19bn
Shares outstanding397m399m358m361m362m362m362m364m362m362m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.08bnCN¥838.5mCN¥594.4mCN¥506.4mCN¥332.9mCN¥664.7mCN¥412.9mCN¥22.3m−CN¥332.6mCN¥108.4m
Capital spending−CN¥184.5m−CN¥147.9m−CN¥172.9m−CN¥183.3m−CN¥264.0m−CN¥261.8m−CN¥249.5m−CN¥271.6m−CN¥189.8m−CN¥127.3m
Free cash flowCN¥893.2mCN¥690.6mCN¥421.5mCN¥323.2mCN¥68.8mCN¥402.9mCN¥163.4m−CN¥249.3m−CN¥522.4m−CN¥18.9m
Dividends paid−CN¥449.5m−CN¥412.4m−CN¥353.8m−CN¥173.9m−CN¥217.5m−CN¥314.5m−CN¥158.7m−CN¥230.2m−CN¥119.2m−CN¥97.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥5.15bnCN¥5.38bnCN¥5.17bnCN¥5.46bnCN¥4.98bnCN¥5.32bnCN¥5.19bnCN¥5.35bn
Gross profitCN¥476.8mCN¥621.6mCN¥597.4mCN¥574.0mCN¥493.0mCN¥639.1mCN¥502.1mCN¥638.1m
Operating incomeCN¥184.5mCN¥357.8mCN¥210.7mCN¥293.1mCN¥195.0mCN¥360.9mCN¥148.7mCN¥341.2m
Net incomeCN¥144.6mCN¥224.6mCN¥63.8mCN¥216.4mCN¥151.9mCN¥277.3mCN¥139.0mCN¥251.7m
Diluted earnings per share0.360.570.160.550.380.700.350.63
Cash from operations———CN¥45.0mCN¥606.0m−CN¥517.0mCN¥730.0mCN¥72.0m
Capital spending−CN¥25.0m−CN¥45.0m−CN¥60.0m−CN¥36.0m−CN¥37.0m−CN¥49.0m−CN¥47.0m−CN¥41.0m
Free cash flow———CN¥9.0mCN¥569.0m−CN¥566.0mCN¥683.0mCN¥31.0m
Total assetsCN¥20.61bnCN¥20.82bnCN¥21.34bnCN¥21.18bnCN¥21.16bnCN¥21.00bnCN¥21.27bnCN¥22.03bn
Cash and short-term investments———CN¥2.69bnCN¥3.31bnCN¥2.61bnCN¥3.68bnCN¥3.30bn
DebtCN¥945.1mCN¥882.0mCN¥540.3mCN¥6.76bnCN¥4.50bnCN¥4.24bnCN¥3.95bnCN¥4.35bn
Shareholders' equityCN¥7.88bnCN¥8.01bnCN¥7.83bnCN¥7.82bnCN¥7.76bnCN¥7.90bnCN¥7.62bnCN¥7.79bn

Financial ratios

Data as of 10 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin11.0%11.3%11.7%11.3%11.2%12.2%
Operating margin5.2%5.8%6.1%5.8%5.4%6.8%
Net margin3.4%4.0%4.1%3.7%3.3%4.5%
Return on equity9.1%11.2%12.8%11.8%10.3%14.0%
Return on assets3.3%4.0%4.2%3.8%3.6%4.8%
Free cash flow yield20.6%16.0%13.8%12.4%10.6%16.5%
Revenue growth-1.2%1.8%9.2%11.2%9.4%5.5%
Earnings growth-17.0%0.6%21.1%24.4%-20.8%3.8%
Current ratio1.51x1.57x1.49x1.49x1.55x1.56x
Debt to equity0.07x0.52x0.65x0.70x0.67x0.71x
Equity ratio36.7%35.8%32.8%32.1%34.4%34.4%
Interest coverage4.93x5.15x5.12x4.57x4.84x5.63x
R&D as a share of sales0.2%0.2%0.2%0.1%0.1%0.1%
Buybacks as a share of market value0.5%-11.3%0.7%0.4%-0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.2%6.0%12.4%
Operating income-0.7%-0.0%15.2%
Net income0.4%-0.1%13.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin11.1%11.3%11.4%11.1%
Operating margin5.0%5.2%5.5%5.6%
Net margin3.7%3.8%3.8%4.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings10.08.38.09.612.211.012.712.922.035.6
Price to sales0.30.30.30.30.40.50.60.60.91.5

Dividends and splits

Per share, in the currency the company pays

Paid for 11 years. Last went ex-dividend on 16 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.680.7510.600.5080.480.600.4860.443
  • 7-for-5 split · 24 Jun 2020
  • 7-for-5 split · 9 May 2018
  • 13-for-10 split · 10 May 2017

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.